Battle and balance at mucosal surfaces - The story of Shigella and antimicrobial peptides

Biochemical and Biophysical Research Communications

Volumn 396, Issue 1, 2010, Pages 116-119

  Gudmundsson, Gudmundur Hrafn ^a   Bergman, Peter ^b   Andersson, Jan ^b   Raqib, Rubhana ^c   Agerberth, Birgitta ^d  

^a UNIVERSITY OF ICELAND   (Iceland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antimicrobial peptides; Cathelicidin; Innate immunity; Shigella

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; BETA DEFENSIN; BUTYRIC ACID; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; FARNESOID X RECEPTOR; LITHOCHOLIC ACID; LYSOZYME; POLYPEPTIDE ANTIBIOTIC AGENT; PREGNANE X RECEPTOR; PROTEINASE; RIBONUCLEASE A; SECRETORY PHOSPHOLIPASE A2; VITAMIN D; VITAMIN D RECEPTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; CONCEPTUAL FRAMEWORK; DEVELOPING COUNTRY; EPITHELIUM CELL; EXPERIMENTAL MODEL; FOOD CONTAMINATION; HUMAN; INFECTION RESISTANCE; INNATE IMMUNITY; MORBIDITY; MORTALITY; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PEPTIDE SYNTHESIS; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; RECEPTOR BINDING; SHIGELLA; SHIGELLOSIS; TH17 CELL; TYPE III SECRETION SYSTEM; WATER CONTAMINATION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BUTYRATES; DISEASE MODELS, ANIMAL; DYSENTERY, BACILLARY; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; INTESTINAL MUCOSA; LITHOCHOLIC ACID; PHENYLBUTYRATES; SHIGELLA; T-LYMPHOCYTES, HELPER-INDUCER; VITAMIN D;

ANIMALIA; SHIGELLA;

EID: 77952318162     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.081     Document Type: Article

References (35)

1. Ogawa M., Handa Y., Ashida H., Suzuki M., and Sasakawa C. The versatility of Shigella effectors. Nat. Rev. Microbiol. 6 (2008) 11-16
2. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., and Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7 (2001) 180-185
3. Sperandio B., Regnault B., Guo J., Zhang Z., Stanley Jr. S.L., Sansonetti P.J., and Pedron T. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J. Exp. Med. 205 (2008) 1121-1132
4. Bergman P., Johansson L., Asp V., Plant L., Gudmundsson G.H., Jonsson A.B., and Agerberth B. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell. Microbiol. 7 (2005) 1009-1017
5. Chakraborty K., Ghosh S., Koley H., Mukhopadhyay A.K., Ramamurthy T., Saha D.R., Mukhopadhyay D., Roychowdhury S., Hamabata T., Takeda Y., and Das S. Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell. Microbiol. 10 (2008) 2520-2537
6. Ray K., Marteyn B., Sansonetti P.J., and Tang C.M. Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat. Rev. Microbiol. 7 (2009) 333-340
7. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., Parsot C., and Sansonetti P.J. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 8 (2007) 47-56
8. Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., and Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol. 12 (2010) 66-73 (sup pp. 1-9)
9. Hamon M.A., Batsche E., Regnault B., Tham T.N., Seveau S., Muchardt C., and Cossart P. Histone modifications induced by a family of bacterial toxins. Proc. Natl. Acad. Sci. USA 104 (2007) 13467-13472
10. Hamon M.A., and Cossart P. Histone modifications and chromatin remodeling during bacterial infections. Cell Host Microbe 4 (2008) 100-109
11. Papayannopoulos V., and Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol. 30 (2009) 513-521
12. Raqib R., Sarker P., Bergman P., Ara G., Lindh M., Sack D.A., Nasirul Islam K.M., Gudmundsson G.H., Andersson J., and Agerberth B. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl. Acad. Sci. USA 103 (2006) 9178-9183
13. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
14. Lai Y., and Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30 (2009) 131-141
15. Agerberth B., and Gudmundsson G.H. Host antimicrobial defence peptides in human disease. Curr. Top. Microbiol. Immunol. 306 (2006) 67-90
16. Schutte B.C., Mitros J.P., Bartlett J.A., Walters J.D., Jia H.P., Welsh M.J., Casavant T.L., and McCray Jr. P.B. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. USA 99 (2002) 2129-2133
17. Bowdish D.M., Davidson D.J., and Hancock R.E. Immunomodulatory properties of defensins and cathelicidins. Curr. Top. Microbiol. Immunol. 306 (2006) 27-66
18. Salzman N.H., Hung K., Haribhai D., Chu H., Karlsson-Sjoberg J., Amir E., Teggatz P., Barman M., Hayward M., Eastwood D., Stoel M., Zhou Y., Sodergren E., Weinstock G.M., Bevins C.L., Williams C.B., and Bos N.A. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11 (2009) 76-83
19. Pedron T., and Sansonetti P. Commensals, bacterial pathogens and intestinal inflammation: an intriguing menage a trois. Cell Host Microbe 3 (2008) 344-347
20. Steinmann J., Halldorsson S., Agerberth B., and Gudmundsson G.H. Phenylbutyrate induces antimicrobial peptide expression. Antimicrob. Agents Chemother. 53 (2009) 5127-5133
21. 3. FASEB J. 19 (2005) 1067-1077
22. 3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173 (2004) 2909-2912
23. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., and Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
24. Termen S., Tollin M., Rodriguez E., Sveinsdottir S.H., Johannesson B., Cederlund A., Sjovall J., Agerberth B., and Gudmundsson G.H. PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol. Immunol. 45 (2008) 3947-3955
25. Adachi R., Honma Y., Masuno H., Kawana K., Shimomura I., Yamada S., and Makishima M. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J. Lipid Res. 46 (2005) 46-57
26. Sina C., Gavrilova O., Forster M., Till A., Derer S., Hildebrand F., Raabe B., Chalaris A., Scheller J., Rehmann A., Franke A., Ott S., Hasler R., Nikolaus S., Folsch U.R., Rose-John S., Jiang H.P., Li J., Schreiber S., and Rosenstiel P. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. 183 (2009) 7514-7522
27. Smith J.J., Travis S.M., Greenberg E.P., and Welsh M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85 (1996) 229-236
28. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima Jr. H., Fellermann K., Ganz T., Stange E.F., and Bevins C.L. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102 (2005) 18129-18134
29. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., and Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347 (2002) 1151-1160
30. Dubin P.J., and Kolls J.K. Th17 cytokines and mucosal immunity. Immunol. Rev. 226 (2008) 160-171
31. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., Davis J., Hsu A., Asher A.I., O'Shea J., Holland S.M., Paul W.E., and Douek D.C. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 (2008) 773-776
32. Ferwerda B., Ferwerda G., Plantinga T.S., Willment J.A., van Spriel A.B., Venselaar H., Elbers C.C., Johnson M.D., Cambi A., Huysamen C., Jacobs L., Jansen T., Verheijen K., Masthoff L., Morre S.A., Vriend G., Williams D.L., Perfect J.R., Joosten L.A., Wijmenga C., van der Meer J.W., Adema G.J., Kullberg B.J., Brown G.D., and Netea M.G. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361 (2009) 1760-1767
33. Glocker E.O., Hennigs A., Nabavi M., Schaffer A.A., Woellner C., Salzer U., Pfeifer D., Veelken H., Warnatz K., Tahami F., Jamal S., Manguiat A., Rezaei N., Amirzargar A.A., Plebani A., Hannesschlager N., Gross O., Ruland J., and Grimbacher B. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361 (2009) 1727-1735
34. Brenchley J.M., and Douek D.C. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 1 (2008) 23-30
35. Peck A., and Mellins E.D. Precarious balance: Th17 cells in host defense. Infect. Immun. 78 (2010) 32-38